132 research outputs found

    Low Power Personalized ECG Based System Design Methodology for Remote Cardiac Health Monitoring

    Get PDF
    This paper describes a mixed-signal ECG system for personalized and remote cardiac health monitoring. The novelty of this work is four-fold. Firstly, a low power analog front end with an efficient automatic gain control mechanism, maintaining the input of the ADC to a level rendering optimum SNR and the enhanced recyclic folded cascode opamp used as an integrator for ADC. Secondly, a novel on-the-fly PQRST Boundary Detection (BD) methodology is formulated for finding the boundaries in continuous ECG signal. Thirdly, a novel low-complexity ECG feature extraction architecture is designed by reusing the same module present in the proposed BD methodology. Fourthly, the system is having the capability to reconfigure the proposed Low power ADC for low (8 bits) and high (12 bits) resolution with the use of the feedback signal obtained from the digital block when it is in processing. The proposed system has been tested and validated on patient’s data from PTBDB, CSEDB and in-house IIT Hyderabad DB (IITHDB) and we have achieved an accuracy of 99% upon testing on various normal and abnormal ECG signals. The whole system is implemented in 180 nm technology resulting in 9.47W (@ 1 MHz) power consumption and occupying 1.74mm2 silicon area

    BRAF wild-type melanoma in situ arising in a BRAF V600E mutant dysplastic nevus

    Get PDF
    IMPORTANCE The BRAF V600E mutation accounts for the majority of BRAF mutations found in cutaneous melanoma and is also commonly found in nevi. We used dermoscopy-targeted sampling and a microbiopsy device coupled with DNA sequence analysis to highlight BRAF V600E heterogeneity within a multicomponent melanocytic proliferation. This sampling technique demonstrates the prospect of in vivo application in a clinical setting

    BRAFV600E Mutation Status of Involuting and Stable Nevi in Dabrafenib Therapy with or without Trametinib

    Get PDF
    IMPORTANCE Recent advances in targeting BRAF(V600E) mutations, which occur in roughly 50% of melanomas and 70% of benign nevi, have improved response rates and survival in patients with melanoma. With increased survival, the importance of other comorbidities increases and requires consideration in long-term management. This case report discusses dynamic dermoscopic nevus changes that occur during dabrafenib therapy and offers some conclusions regarding BRAF mutations and the changes

    Primary choriocarcinoma of the renal pelvis presenting as intracerebral hemorrhage: a case report and review of the literature

    Get PDF
    <p>Abstract</p> <p>Introduction</p> <p>A choriocarcinoma is a malignant neoplasm normally arising in the gestational trophoblast, gonads and, less frequently, the retroperitoneum, mediastinum and pineal gland. Primary choriocarcinomas of the renal pelvis are extremely rare.</p> <p>Case presentation</p> <p>We report a case of primary choriocarcinoma of the renal pelvis in a 38-year-old Greek woman of reproductive age, presenting with a sudden development of intracerebral hemorrhage due to metastatic lesions. The diagnosis was established with a renal biopsy, along with an elevated serum level of beta-human chorionic gonadotropin. An extensive diagnostic work up confirmed the origin of the choriocarcinoma to be the renal pelvis.</p> <p>Conclusion</p> <p>Extragonadal choriocarcinomas are rare neoplasms that require extensive laboratory and imaging studies to exclude a gonadal origin. Moreover, this is the first case of severe intracerebral hemorrhage as the initial presentation of primary choriocarcinoma of the renal pelvis. Nonetheless, choriocarcinomas should be considered in the differential diagnosis of women of reproductive age.</p

    Whole-exome sequencing of acquired nevi identifies mechanisms for development and maintenance of benign neoplasms

    Get PDF
    The melanoma transformation rate of each nevus is rare despite the detection of oncogenic BRAF or NRAS mutations in 100% of nevi. Acquired melanocytic nevi (AMN) do however mimic melanoma and ∼30% of all melanomas arise within pre-existing nevi. Using whole-exome sequencing of 30 matched nevi, adjacent normal skin, and saliva we sought to identify the underlying genetic mechanisms for nevus development. All nevi were clinically, dermoscopically, and histopathologically documented. In addition to identifying somatic mutations, we found mutational signatures relating to ultra-violet radiation (UVR) mirroring those found in cutaneous melanoma. In nevi we frequently observed the presence of the UVR mutation signature compared to adjacent normal skin (97% vs 10% respectively). In copy number aberration (CNA) analysis, in nevi with copy number loss of tumor suppressor genes (TSG), these were balanced by loss of potent oncogenes. Moreover, reticular and non-specific patterned nevi revealed an increased (

    Germline MC1R status influences somatic mutation burden in melanoma

    Get PDF
    The major genetic determinants of cutaneous melanoma risk in the general population are disruptive variants (R alleles) in the melanocortin 1 receptor (MC1R) gene. These alleles are also linked to red hair, freckling, and sun sensitivity, all of which are known melanoma phenotypic risk factors. Here we report that in melanomas and for somatic C>T mutations, a signature linked to sun exposure, the expected single-nucleotide variant count associated with the presence of an R allele is estimated to be 42% (95% CI, 15-76%) higher than that among persons without an R allele. This figure is comparable to the expected mutational burden associated with an additional 21 years of age. We also find significant and similar enrichment of non-C>T mutation classes supporting a role for additional mutagenic processes in melanoma development in individuals carrying R alleles

    Overexpression of cathepsin K during silica-induced lung fibrosis and control by TGF-β

    Get PDF
    BACKGROUND: Lung fibrosis is characterized by tissue remodeling resulting from an imbalance between synthesis and degradation of extracellular organic matrices. To examine whether cathepsin(s) (Cat) are important in the development of pulmonary fibrosis, we assessed the expression of four Cat known for their collagenolytic activity in a model of silica-induced lung fibrosis. METHODS: Different strains of mice were transorally instilled with 2.5 mg crystalline silica or other particles. Cat expression (Cat K, S, L and B) was quantified in lung tissue and isolated pulmonary cells by quantitative RT-PCR. In vitro, we assessed the effect of different cytokines, involved in lung inflammatory and fibrotic responses, on the expression of Cat K by alveolar macrophages and fibroblasts. RESULTS: In lung tissue, Cat K transcript was the most strongly upregulated in response to silica, and this upregulation was intimately related to the fibrotic process. In mouse strains known for their differential response to silica, we showed that the level of Cat K expression following silica treatment was inversely related to the level of TGF-β expression and the susceptibility of these strains to develop fibrosis. Pulmonary macrophages and fibroblasts were identified as Cat K overproducing cells in the lung of silicotic mice. In vitro, Cat K was downregulated in mouse and human lung fibroblasts by the profibrotic growth factor TGF-β1. CONCLUSION: Altogether, these data suggest that while Cat K may contribute to control lung fibrosis, TGF-β appears to limit its overexpression in response to silica particles

    A randomised controlled trial of the Neuro Emotional Technique (NET) for childhood Attention Deficit Hyperactivity Disorder (ADHD): a protocol

    Get PDF
    <p>Abstract</p> <p>Background</p> <p>An abundance of literature is dedicated to research for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). Most, is in the area of pharmacological therapies with less emphasis in psychotherapy and psychosocial interventions and even less in the area of complementary and alternative medicine (CAM).</p> <p>The use of CAM has increased over the years, especially for developmental and behavioral disorders, such as ADHD. 60–65% of parents with children with ADHD have used CAM. Medical evidence supports a multidisciplinary approach (i.e. pharmacological and psychosocial) for the best clinical outcomes. The Neuro Emotional Technique (NET), a branch of Chiropractic, was designed to address the biopsychosocial aspects of acute and chronic conditions including non-musculoskeletal conditions. Anecdotally, it has been suggested that ADHD may be managed effectively by NET.</p> <p>Design/methods</p> <p>A placebo controlled, double blind randomised clinical trial was designed to assess the effectiveness of NET on a cohort of children with medically diagnosed ADHD.</p> <p>Children aged 5–12 years who met the inclusion criteria were randomised to one of three groups. The control group continued on their existing medical regimen and the intervention and placebo groups had the addition of the NET and sham NET protocols added to their regimen respectively. These two groups attended a clinical facility twice a week for the first month and then once a month for six months.</p> <p>The Conners' Parent and Teacher Rating Scales (CRS) were used at the start of the study to establish baseline data and then in one month and in seven months time, at the conclusion of the study. The primary outcome measures chosen were the Conners' ADHD Index and Conners' Global Index. The secondary outcome measures chosen were the DSM-IV: Inattentive, the DSM-IV:Hyperactive-Impulsive, and the DSM-IV:Total subscales from the Conners' Rating Scales, monitoring changes in inattention, hyperactivity and impulsivity.</p> <p>Calculations for the sample size were set with a significance level of 0.05 and the power of 80%, yielding a sample size of 93.</p> <p>Discussion</p> <p>The present study should provide information as to whether the addition of NET to an existing medical regimen can improve outcomes for children with ADHD.</p> <p>Trial registration</p> <p>Australian New Zealand Clinical Trial Registration Number: ANZCTRN 012606000332527</p

    Small molecule binding and activation on a cationic ruthenium center of a pincer complex

    No full text
    Ruthenium pincer complex RuHCl(PPh3)(PNP)] (PNP = Me-N(CH2CH2PPh2)(2)) (1) was synthesized by reaction of RuHCl(PPh3)(3) with Me-N(CH2CH2PPh2)(2) and characterized. Abstraction of chloride ligand in complex 1 using NaBA(4)(f) in the presence of small molecules such as N-2, H-2, O-2, and CO resulted in the formation of trans-RuH(L)(PPh3)(PNP)]BAr4f {L = N-2 (2), H-2 (4), O-2 (5), CO (6)} complexes. Complexes 2, 4, 5, and 6 have been characterized by various techniques. The reaction of RuHCl(PPh3)(PNP)] complex with NaBH4 gave a borohydrido complex RuH(eta(1)-BH4)(PPh3)(PNP)] (7) which upon reaction with NEt3 generates a mixture of cis and trans dihydrides RuH2(PPh3)(PNP)] (8). The reaction of dihydride complexes with CO2 leads to the formation of formate complex RuH(eta(1)-HCO2)(PPh3)(PNP)] (9). In addition, dihydrogen complexes Ru(eta(2)-H-2)(L)(PPh3)(PNP)](n+) (L = Cl (10), CO (11)) having different trans donor ligands were synthesized by protonation of trans-RuH(L)(PPh3)(PNP)](n+) {n = 0, L = CI; n = 1, L = CO} complexes with HOTf at low temperature. Complexes I and 6 have been characterized by X-ray crystallography. (C) 2016 Elsevier B.V. All rights reserved
    corecore